Exosome Diagnostics & Therapeutics: 2018 Global Market Report - ResearchAndMarkets.com

July 6, 2018

DUBLIN--(BUSINESS WIRE)--Jul 6, 2018--The “Exosome Diagnostics and Therapeutics: Global Markets” report has been added to ResearchAndMarkets.com’s offering.

Initially, exosome particles were considered garbage molecules secreted by cells. Today, many researchers are convinced that these tiny vesicles have unlimited potential in diagnostics and therapeutics, especially in oncology treatments.

Research shows that all fluids in the human body contain exosomes which can transfer cytoplasmic ingredients to other cells either locally or at distant sites. Once reaching the recipient cells, cytoplasmic ingredients can alter their biology.

Scientists believe that various biomolecules in exosomes can be profiled and, consequently, may serve as useful biomarkers for different diseases. Nucleic acids such as RNA or DNA can be isolated from exosomes and further analyzed by various techniques.

Overall, the market for the exosome approach can be divided into three main categories: diagnostics, therapeutics, and research tools.

This report evaluates the diagnostics market affected by exosome research and further potential of exosome-based tests and assays. Indeed, an exosomes approach represents the opportunity to expand and develop the liquid biopsy market, a growing sector in cancer diagnostics.

This report also highlights developments in therapeutics and drug development sectors. There is a significant potential for using exosome depletion as a way of treating disease; cancer-generated exosomes can inhibit the immune response and stimulate angiogenesis, the development of new blood vessels. Consequently, if these exosomes are removed, tumor growth might be inhibited, and anticancer agents can work more efficiently.

In addition, there is a potential for exosomes to be used as targeted delivery vehicles of therapeutic molecules to cancer cells; for example, delivering small interfering RNA-specific molecules (siRNA) for a particular oncogene expressed in a tumor cell.

Life science tool companies develop unique research tools for exosome detection and isolation. Current products offered in this area of industry are discussed in this report.

Although many scientific questions still need to be answered, exosomes serve as a novel and unique platform in the diagnostics and therapeutic sectors. Altogether, exosomes offer a new alternative to current diagnostics and drug development technologies.

Key Topics Covered

1 Introduction

2 Summary and Highlights

3 Market and Technology Background

4 Exosome Diagnostics Market

5 Exosome Therapeutic Market

6 Exosome Reagents and Research Tools Market

7 Impact of Exosome Research on Specific Biopharmaceuticals Market

8 Patent Review/New Developments

9 Market Summary

10 Company Profiles

Codiak Biosciences Evox Therapeutics Ltd. Exosome Diagnostics Inc. Hansabiomed Life Sciences Ltd. (Lonza) Nanosomix Inc. System Biosciences (SBI)

For more information about this report visit https://www.researchandmarkets.com/research/xk4p6b/exosome?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180706005436/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Diagnostics



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/06/2018 04:51 PM/DISC: 07/06/2018 04:50 PM


Update hourly